Inhibition of Interleukin‐3‐Dependent Growth of CD34⁺ Acute Myelogenous Leukemia Cells by Recombinant Soluble CD23^a

This publication has 12 references indexed in Scilit:

• Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity.
  The Journal of Experimental Medicine, 1990
• Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.
  The Journal of Experimental Medicine, 1990
• Human IgE-binding factors
  Immunology Today, 1989
• CD23: a multi-functional receptor/ lymphokine?
  Immunology Today, 1989
• Expression and functional role of CD23 on T cells
  European Journal of Immunology, 1989
• Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells
  Blood, 1988
• Interleukin 5 enhances interleukin 4‐induced IgE production by normal human B cells. The role of soluble CD23 antigen
  European Journal of Immunology, 1988
• The Human Hematopoietic Colony-Stimulating Factors
  Science, 1987
• Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1
  Cell, 1986
• Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.
  The Journal of Immunology, 1984